A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes
Status:
Not yet recruiting
Trial end date:
2023-07-27
Target enrollment:
Participant gender:
Summary
The study compares two semaglutide medicines and looks at how well they control blood sugar
levels, in participants with type 2 diabetes (T2D). Participants will either get the
currently available semaglutide or the semaglutide which is produced through a new
manufacturing process. Participants need to take one injection of semaglutide once a week, on
the same day of every week. Participants will have a total of 11 clinic visits and the study
will last for about 35 weeks (approximately 8 months).